Exercise linked to better fitness and quality of life in breast cancer survivors
A meta-analysis of 32 trials involving 1,754 breast cancer survivors found that exercise was associated with significant improvements in peak oxygen consumption and quality of life, but showed no detectable effect on inflammatory markers like C-reactive protein or interleukin-6.
Breast cancer survivors often face lasting treatment effects—reduced cardiorespiratory fitness, chronic inflammation, and lower quality of life—even after the active treatment phase ends. Researchers conducted a systematic review and meta-analysis of 32 randomized controlled trials published through April 2025, involving 1,754 survivors, to assess whether exercise could address these burdens.
The analysis found that exercise was significantly associated with improved peak oxygen consumption (the amount of oxygen the body can use during intense effort), with a weighted mean difference of 1.22 mL/kg/min (p < 0.001). Quality of life also improved measurably: general QOL showed a weighted mean difference of 6.05 points and breast cancer–specific QOL showed 5.13 points, both statistically significant. However, the same exercise interventions showed no significant effects on maximum oxygen consumption, C-reactive protein, interleukin-6, or tumor necrosis factor-alpha—three key inflammatory markers (p > 0.05 for all). The findings suggest that while exercise reliably supports fitness gains and well-being in this population, its mechanism may not primarily work through reducing systemic inflammation, at least as measured by these common biomarkers.
The meta-analysis pooled data across a range of exercise formats—aerobic training, resistance work, and combined protocols—suggesting the benefit was not tied to one specific type. Peak oxygen consumption gains of ~1.2 mL/kg/min represent a clinically meaningful shift in aerobic capacity; for perspective, this is similar to gains seen in healthy adults after 6–8 weeks of moderate-intensity training. The absence of detectable change in C-reactive protein, IL-6, and TNF-α is striking given that inflammation is often cited as a mechanism. This may reflect either that inflammation is not the primary pathway, that the time windows or measurement protocols in existing trials were not optimal for detecting systemic inflammation changes, or that local tissue effects matter more than circulating markers. The QOL improvement (5–6 point shifts on common scales) tends to persist as long as exercise is maintained, suggesting adherence is key. Notably, the review included primarily aerobic and resistance studies; more work on high-intensity interval training or novel modalities in cancer survivors is limited.
The deeper explanation, the effect sizes and caveats, and what this means for your own sleep, exercise and reading — read it inside Cadence.
Open in Cadence →References
- Impact of Exercise on QOL, Cardiorespiratory Function, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. — Oncology nursing forum (Read the original)